Article Text


  1. S. Aminpour
  1. University of California, Davis School of Medicine


Hypothesis Blockade of tumor necrosis factor α (TNF-α) with TNF-α antibody will reduce the extent of intracochlear fibrosis, ossification, and hearing loss associated with Streptococcus pneumoniae meningitis.

Background Inflammatory mediators play a significant role in the morbidity associated with bacterial meningitis including hearing loss and labyrinthitis ossificans. Previous studies have shown the attenuation of hearing loss by the non-specific blockade of such pathways.

Methods Fifty Mongolian gerbils were divided into 4 groups. Auditory brainstem response testing (ABR) was conducted to measure hearing thresholds. Streptococcus pneumoniae meningitis was induced in groups 1 and 2. Group 2 was then given a single intraperitoneal injection of TNF-α antibody while group 1 received normal saline. Uninfected animals in groups 3 and 4 were implanted with osmotic pumps that delivered a continuous 8 day intrathecal flow of either TNF-α or phosphate buffered saline (PBS). After 6 weeks, ABR testing was repeated.

Results Group 2 animals with S. pneumoniae meningitis which also received TNF-α antibody developed significantly less hearing loss than group 1 animals with meningitis alone. The decrease in the average threshold at 4, 8, 16, and 32 kHz was 31, 30, 25, and 28 dB SPL respectively (P ≤ 0.0092 for each). Furthermore, histomorphometric analysis showed significantly less damage to the organ of Corti, spiral ganglion, spiral ligament, and stria vascularis in group 2. Conversely, TNF-α induced meningitis animals (group3) showed increased hearing loss compared to PBS controls (group4) with P ≤ 0.0001 at all frequencies.

Conclusions TNF-α plays an important role in cochlear injury following bacterial meningitis. Blockade of TNF-α reduces post-meningitic hearing loss and cochlear injury. Induction of meningitis with intrathecal also resulted in hearing loss and cochlear injury similar to bacterial meningitis.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.